Efg Asset Management (Americas) Corp. Johnson & Johnson Transaction History

Efg Asset Management (Americas) Corp.

$508 Million
Q3 2024

A detailed history of Efg Asset Management (Americas) Corp. transactions in Johnson & Johnson stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 54,958 shares of JNJ stock, worth $8.02 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

54,958

Previous 58,409 5.91%

Holding current value

$8.02 Million

Previous $8.54 Million 4.32%

% of portfolio

1.75%

Previous 1.68%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $502,051 - $577,628	-3,451 Reduced 5.91%	54,958 $8.91 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $2.39 Million - $2.61 Million	16,549 Added 39.53%	58,409 $8.54 Million
Q1 2024 Apr 22, 2024	SELL	$155.22 - $162.74 $2.52 Million - $2.65 Million	-16,264 Reduced 27.98%	41,860 $6.62 Million
Q4 2023 Feb 01, 2024	SELL	$145.6 - $158.88 $202,092 - $220,525	-1,388 Reduced 2.33%	58,124 $9.11 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $62,611 - $70,140	-402 Reduced 0.67%	59,512 $9.27 Million
Q2 2023 Aug 29, 2023	SELL	$154.35 - $166.11 $73,316 - $78,902	-475 Reduced 0.79%	59,914 $9.92 Million
Q1 2023 May 04, 2023	SELL	$151.05 - $180.26 $40,028 - $47,768	-265 Reduced 0.44%	60,389 $9.36 Million
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $444,715 - $499,097	-2,776 Reduced 4.38%	60,654 $10.7 Million
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $440,430 - $490,089	-2,730 Reduced 4.13%	63,430 $10.4 Million
Q2 2022 Jul 13, 2022	BUY	$168.19 - $186.01 $9.54 Million - $10.5 Million	56,714 Added 600.4%	66,160 $11.8 Million
Q1 2022 May 05, 2022	BUY	$158.14 - $179.59 $17,079 - $19,395	108 Added 1.16%	9,446 $1.67 Million
Q4 2021 Jan 24, 2022	SELL	$155.93 - $173.01 $144,391 - $160,207	-926 Reduced 9.02%	9,338 $1.6 Million
Q3 2021 Oct 22, 2021	BUY	$161.5 - $179.47 $69,768 - $77,531	432 Added 4.39%	10,264 $1.66 Million
Q2 2021 Jul 23, 2021	BUY	$159.48 - $171.07 $171,441 - $183,900	1,075 Added 12.28%	9,832 $1.62 Million
Q1 2021 Apr 09, 2021	SELL	$153.07 - $170.48 $278,740 - $310,444	-1,821 Reduced 17.21%	8,757 $1.44 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $44,286 - $50,833	323 Added 3.15%	10,578 $1.67 Million
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $311,783 - $341,656	-2,221 Reduced 17.8%	10,255 $1.53 Million
Q2 2020 Jul 30, 2020	BUY	$128.81 - $155.51 $193,859 - $234,042	1,505 Added 13.72%	12,476 $1.75 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $11,780 - $16,322	106 Added 0.98%	10,971 $1.44 Million
Q4 2019 Jan 28, 2020	BUY	$127.5 - $146.44 $715,402 - $821,674	5,611 Added 106.79%	10,865 $1.59 Million
Q3 2019 Nov 05, 2019	BUY	$126.95 - $142.14 $148,150 - $165,877	1,167 Added 28.55%	5,254 $680,000
Q2 2019 Jul 09, 2019	SELL	$131.15 - $144.24 $217,315 - $239,005	-1,657 Reduced 28.85%	4,087 $569,000
Q1 2019 Apr 05, 2019	BUY	$125.72 - $139.79 $280,858 - $312,290	2,234 Added 63.65%	5,744 $803,000
Q4 2018 Feb 06, 2019	SELL	$122.84 - $147.84 $92,989 - $111,914	-757 Reduced 17.74%	3,510 $453,000
Q3 2018 Oct 09, 2018	SELL	$121.58 - $142.88 $36,474 - $42,864	-300 Reduced 6.57%	4,267 $590,000
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $39,640 - $43,744	-332 Reduced 6.78%	4,567 $554,000
Q1 2018 May 07, 2018	SELL	$125.1 - $148.14 $212,044 - $251,097	-1,695 Reduced 25.71%	4,899 $628,000
Q4 2017 Feb 07, 2018	BUY	$131.22 - $143.62 $28,605 - $31,309	218 Added 3.42%	6,594 $921,000
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $380,382 - $397,746	-2,938 Reduced 31.54%	6,376 $829,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,314	9,314 $1.27 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.

Account

Efg Asset Management (Americas) Corp. Johnson & Johnson Transaction History